Skip to content

Regencell Bioscience Holdings Ltd

RGC· NasdaqCore metricsCIK 1829667

Medicinal chemicals & botanical products40 peers

Last sale
Nov 12, 2026 · -6.24%
Market cap
$2.53B
495.88M shares
Filings
86
—
—
—
-$11.70M
FY 2026N/M FY26 yoy
-$11.72M
FY 2026N/M FY26 yoy
-$3.27M
FY 2025derivedN/M FY25 yoy
-$2.37
FY 2026N/M FY26 yoy
$14.19M
FY 2026+486.7% FY26 yoy
$2.53B
—
—
189.8×
—
—

FY2026 figures · derived

Price

$5.1164.86%$9.43past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$1.30MFY 2026
$2.51M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$1,299,627reported
FY 20252025-06-30$948,289reported
FY 20242024-06-30$1,066,233reported
FY 20232023-06-30$1,581,628reported
FY 20222022-06-30$2,512,154reported
FY 20212021-06-30$438,323reported
FY 20202020-06-30$386,230reported
FY 20192019-06-30$228,223reported

Medicinal chemicals & botanical products

Regencell Bioscience Holdings Ltd is the 2nd largest of the 41 covered companies the SEC files under this code, by market cap. SIC 2833

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Regencell Bioscience Holdings Ltd · CIK 1829667 · Engraved from SEC EDGAR